Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001683168-23-006200)

Filing Details

Accession Number:: 0001683168-23-006200
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-31 16:01:06
Reporting Period:: 2023-08-23

Accepted Time:: 2023-08-31 16:01:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759186	Coeptis Therapeutics Holdings Inc.	COEP	Biological Products, (No Disgnostic Substances) (2836)	981465952

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1824769	Chris Calise	105 Bradford Road, Suite 420 Wexford PA 15090		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-23	9,000	$0.94	1,462,315	No	4	P	Direct
Common Stock	Acquisiton	2023-08-23	2,582	$0.94	1,464,897	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes (i) 942,117 shares of common stock that are issuable under currently exercisable options and (ii) 7,500 shares of common stock that are issuable upon exercise of options that will become exercisable. Does not include 22,500 shares of common stock that are issuable upon exercise of options that are not currently exercisable and will not become exercisable in the next 60 days.